Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 75 Neoplasms 15 Neoplasm Metastasis 9 Advanced Breast Cancer 5 Neoplasms by Site 3 Breast Diseases 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Patient Compliance 2 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases 1 Recurrence 1 Quality of Life 1 Osteoporosis 1 Multiple Endocrine Neoplasia Type 1 1 Low Grade Serous Ovarian Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Joint Diseases 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Cancer Metastatic 1 Bone Diseases, Metabolic 1 Bone Density 1 Arthralgia 1 Advanced Metastatic Breast Cancer 1

Interventions

Zoledronic Acid 4 Letrozole 2 Kyphoplasty 2 Denosumab 2 Toremifene 1 Testosterone 1 Risedronic Acid 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Osteoporosis × Anastrozole × Clear all

NCT00082277 2011-01-26

SABRE

AstraZeneca

Phase 4 Completed

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡